Curis preclinical data

In mouse xenograft models of cancer, 50 mg/kg IV CUDC-907 and 100 mg/kg oral CUDC-907 both led to stable disease in models of diffuse large B cell lymphoma (DLBCL) and non-small cell lung cancer (NSCL...